MSU Breslin Cancer Center

Lansing, Michigan 48910

We've found

2 trials

at this facility

Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)

Status: Enrolling, Phase III
Updated: 4/17/2014

from

Lansing, MI

Using SMART Design to Improve Symptom Management Strategies Among Cancer Patients

Status: Enrolling
Updated: 12/31/1969

from

Lansing, MI

Use our guide to learn which trials are right for you!